BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32618052)

  • 21. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer].
    Sadick M; Schoenberg SO; Hoermann K; Sadick H
    Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S27-47. PubMed ID: 22456918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
    Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
    Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
    Busquets JM; García HA; Trinidad-Pinedo J; Baez A
    P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.
    Wong TH; Skanthakumar T; Nadkarni N; Nguyen HV; Iyer NG
    Cancer; 2017 Jun; 123(11):1998-2005. PubMed ID: 28135397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
    Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of level V metastasis in head and neck squamous cell carcinoma.
    Kainuma K; Yano T; Kitoh R; Naito T; Usami S
    Acta Otolaryngol; 2013 Feb; 133(2):218-24. PubMed ID: 23145939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
    Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of routine esophageal screening in patients with head and neck cancer.
    Su YY; Chen WC; Chuang HC; Guo CS; Lin YT; Luo SD; Fang FM; Chien CY
    JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):350-4. PubMed ID: 23519755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative simultaneous fractionated cisplatin and radiation therapy in the treatment of advanced operable stage III and IV squamous cell carcinoma of the head and neck.
    Davis MA; Tyrrell J; Slotman GJ; Sudhindra R; Sachdeva K; Fanelle J; Smith G; Wurzer JV; Cassir J; Nazha NT;
    Am J Surg; 2015 Mar; 209(3):575-9. PubMed ID: 25557972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affiliation to the work market after curative treatment of head-and-neck cancer: a population-based study from the DAHANCA database.
    Kjær T; Bøje CR; Olsen MH; Overgaard J; Johansen J; Ibfelt E; Steding-Jessen M; Johansen C; Dalton SO
    Acta Oncol; 2013 Feb; 52(2):430-9. PubMed ID: 23282115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.
    Kurzweg T; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Lörincz BB; Schuler PJ; Laban S
    HNO; 2016 Jul; 64(7):501-7. PubMed ID: 27357174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma.
    Knopf A; Teutsch S; Bier H
    BMC Health Serv Res; 2021 Jan; 21(1):45. PubMed ID: 33419421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
    Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
    Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
    Nagasaka M; Zaki M; Issa M; Kim H; Abrams J; Sukari A
    Laryngoscope; 2017 Oct; 127(10):2260-2264. PubMed ID: 28271529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.